• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质类固醇在神经囊尾蚴病中的应用。

Corticosteroid use in neurocysticercosis.

机构信息

Laboratory of Parasitic Diseases, NIAID, NIH, 4 Center Drive, Building 4, Room 126, Bethesda, MD 20892, USA.

出版信息

Expert Rev Neurother. 2011 Aug;11(8):1175-83. doi: 10.1586/ern.11.86.

DOI:10.1586/ern.11.86
PMID:21797658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3721198/
Abstract

The cystic larvae of Taenia solium commonly infect the human nervous system, resulting in neurocysticercosis, a major contributor to seizure disorders in most of the world. Inflammation around the parasites is a hallmark of neurocysticercosis pathophysiology. Although mechanisms regulating this inflammation are poorly understood, anti-inflammatory drugs, particularly corticosteroids, have been long used alone or with anthelmintics to manage disease and limit neurological complications and perhaps damage to neural tissues. Only scarce controlled data exist to determine when and what type of corticosteroids and the treatment regime to use. This article revisits the mechanisms of action, rationale, evidence of benefit, safety and problems of corticosteroids in the context of neurocysticercosis, as well as alternative anti-inflammatory strategies to limit the damage caused by inflammation in the CNS.

摘要

猪带绦虫的囊尾蚴通常会感染人体神经系统,导致囊虫病,这是世界上大多数癫痫发作的主要原因。寄生虫周围的炎症是囊虫病病理生理学的一个标志。尽管调节这种炎症的机制还不清楚,但抗炎药物,特别是皮质类固醇,长期以来一直被单独使用或与驱虫药一起用于治疗疾病,以限制神经并发症并可能减轻对神经组织的损害。目前仅有少量对照数据可以确定何时以及使用哪种类型的皮质类固醇以及治疗方案。本文重新审视了皮质类固醇在囊虫病中的作用机制、原理、获益证据、安全性和问题,以及限制 CNS 炎症造成损害的替代抗炎策略。

相似文献

1
Corticosteroid use in neurocysticercosis.皮质类固醇在神经囊尾蚴病中的应用。
Expert Rev Neurother. 2011 Aug;11(8):1175-83. doi: 10.1586/ern.11.86.
2
Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent.实质性神经囊尾蚴病治疗后长时间的病灶周围水肿:甲氨蝶呤作为一种皮质类固醇替代药物
Clin Infect Dis. 2003 May 15;36(10):e122-6. doi: 10.1086/374667. Epub 2003 May 9.
3
Human Extraparenchymal Neurocysticercosis: The Control of Inflammation Favors the Host…but Also the Parasite.人类脑外神经囊尾蚴病:炎症的控制对宿主有利……但对寄生虫也有利。
Front Immunol. 2018 Nov 16;9:2652. doi: 10.3389/fimmu.2018.02652. eCollection 2018.
4
Inflammation in neurocysticercosis: clinical relevance and impact on treatment decisions.神经囊虫病中的炎症:临床相关性及其对治疗决策的影响。
Expert Rev Anti Infect Ther. 2021 Dec;19(12):1503-1518. doi: 10.1080/14787210.2021.1912592. Epub 2021 Apr 9.
5
Diagnosis and treatment of neurocysticercosis.脑囊尾蚴病的诊断与治疗。
Nat Rev Neurol. 2011 Sep 13;7(10):584-94. doi: 10.1038/nrneurol.2011.135.
6
Neurocysticercosis an uncommon intra-cerebral infection in Malaysia.神经囊尾蚴病在马来西亚是一种不常见的脑内感染。
Med J Malaysia. 2005 Oct;60(4):514-6.
7
Host immune responses during Taenia solium Neurocysticercosis infection and treatment.猪带绦虫性神经囊尾蚴病感染和治疗期间的宿主免疫反应。
PLoS Negl Trop Dis. 2020 Apr 16;14(4):e0008005. doi: 10.1371/journal.pntd.0008005. eCollection 2020 Apr.
8
Neurocysticercosis: radiologic-pathologic correlation.神经囊虫病:放射-病理相关性。
Radiographics. 2010 Oct;30(6):1705-19. doi: 10.1148/rg.306105522.
9
Oxfendazole Nitazoxanide combination in experimental neurocysticercosis - Anti-inflammatory and cysticidal effects.奥硝唑-硝唑尼特联合治疗实验性神经囊虫病的抗炎和杀囊作用。
Exp Parasitol. 2024 Jul;262:108764. doi: 10.1016/j.exppara.2024.108764. Epub 2024 Apr 25.
10
Detection of DNA in the Urine of Neurocysticercosis Patients.检测神经囊虫病患者尿液中的 DNA。
Am J Trop Med Hyg. 2019 Feb;100(2):327-329. doi: 10.4269/ajtmh.18-0706.

引用本文的文献

1
Obstructive hydrocephalus: when subarachnoid cysts alert to the challenging diagnosis of neurocysticercosis.梗阻性脑积水:当蛛网膜囊肿提示神经囊尾蚴病这一具有挑战性的诊断时。
Quant Imaging Med Surg. 2025 Apr 1;15(4):3759-3764. doi: 10.21037/qims-24-1822. Epub 2025 Mar 25.
2
Ivermectin as a promising therapeutic option for onchocerciasis-associated epilepsy.伊维菌素作为治疗盘尾丝虫病相关癫痫的一种有前景的治疗选择。
Epilepsia Open. 2025 Feb;10(1):361-367. doi: 10.1002/epi4.13107. Epub 2024 Nov 25.
3
Murine Extraparenchymal Neurocysticercosis: Appropriate Model for Evaluating Anthelminthic and Anti-Inflammatory Treatment Schedules.

本文引用的文献

1
Short report: A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features.短篇报告:与复发性瘤周水肿引起难治性癫痫相关的钙化猪带绦虫肉芽肿:组织病理学特征。
Am J Trop Med Hyg. 2011 Sep;85(3):460-3. doi: 10.4269/ajtmh.2011.11-0221.
2
The role of the glucocorticoid receptor in inflammation and immunity.糖皮质激素受体在炎症和免疫中的作用。
J Steroid Biochem Mol Biol. 2010 May 31;120(2-3):69-75. doi: 10.1016/j.jsbmb.2010.03.058. Epub 2010 Mar 24.
3
Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors.
小鼠脑外神经囊尾蚴病:评估驱虫和抗炎治疗方案的合适模型。
Trop Med Infect Dis. 2024 Sep 16;9(9):215. doi: 10.3390/tropicalmed9090215.
4
Transcriptomic analysis of subarachnoid cysts of Taenia solium reveals mechanisms for uncontrolled proliferation and adaptations to the microenvironment.猪带绦虫蛛网膜下腔囊肿的转录组分析揭示了不受控制的增殖机制和对微环境的适应。
Sci Rep. 2024 May 23;14(1):11833. doi: 10.1038/s41598-024-61973-9.
5
Demographics and Clinical Characteristics of Patients with Neurocysticercosis: A Retrospective Study from Dali, China.神经囊尾蚴病患者的人口统计学和临床特征:来自中国大理的一项回顾性研究
Saudi J Med Med Sci. 2023 Oct-Dec;11(4):283-291. doi: 10.4103/sjmms.sjmms_298_23. Epub 2023 Oct 6.
6
Triggered: Discovery of Neurocysticercosis Following Self-Administered Albendazole.引发:自我服用阿苯达唑后发现神经囊尾蚴病
Cureus. 2023 Aug 19;15(8):e43746. doi: 10.7759/cureus.43746. eCollection 2023 Aug.
7
Human Neurocysticercosis: An Overview.人类神经囊尾蚴病:概述
Pathogens. 2022 Oct 20;11(10):1212. doi: 10.3390/pathogens11101212.
8
Community-level prevalence of epilepsy and of neurocysticercosis among people with epilepsy in the Balaka district of Malawi: A cross-sectional study.马拉维巴兰卡地区癫痫患者的癫痫和神经囊虫病的社区流行率:一项横断面研究。
PLoS Negl Trop Dis. 2022 Sep 15;16(9):e0010675. doi: 10.1371/journal.pntd.0010675. eCollection 2022 Sep.
9
Current Diagnostic Criteria for Neurocysticercosis.神经囊尾蚴病的现行诊断标准。
Res Rep Trop Med. 2021 Aug 10;12:197-203. doi: 10.2147/RRTM.S285393. eCollection 2021.
10
Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world.脑囊虫病。在世界上大多数地区,它是导致癫痫发作、癫痫和其他神经疾病的常见原因。
J Neurol Sci. 2021 Aug 15;427:117527. doi: 10.1016/j.jns.2021.117527. Epub 2021 Jun 17.
人类脑囊尾蚴病的临床异质性是由寄生虫、宿主和环境因素之间的复杂相互作用引起的。
Trans R Soc Trop Med Hyg. 2010 Apr;104(4):243-50. doi: 10.1016/j.trstmh.2010.01.005. Epub 2010 Jan 29.
4
Mesocestoides corti intracranial infection as a murine model for neurocysticercosis.细颈囊尾蚴颅内感染作为神经囊虫病的小鼠模型。
Parasitology. 2010 Mar;137(3):359-72. doi: 10.1017/S0031182009991971. Epub 2010 Jan 29.
5
Cysticercosis and neurocysticercosis as pathogens affecting the nervous system.囊尾蚴病和神经囊尾蚴病作为影响神经系统的病原体。
Prog Neurobiol. 2010 Jun;91(2):172-84. doi: 10.1016/j.pneurobio.2009.12.008. Epub 2009 Dec 24.
6
Neurocysticercosis in children.儿童神经囊尾蚴病
Indian J Pediatr. 2009 May;76(5):537-45. doi: 10.1007/s12098-009-0139-5. Epub 2009 May 24.
7
New developments in the management of neurocysticercosis.神经囊尾蚴病治疗的新进展
J Infect Dis. 2009 May 1;199(9):1261-2. doi: 10.1086/597758.
8
Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.综述:糖皮质激素抗炎作用的最新观点
Mol Endocrinol. 2009 Mar;23(3):281-91. doi: 10.1210/me.2008-0283. Epub 2008 Dec 18.
9
Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study.钙化性神经囊尾蚴病患者的病灶周围脑水肿和癫痫活动:一项前瞻性队列研究和巢式病例对照研究
Lancet Neurol. 2008 Dec;7(12):1099-105. doi: 10.1016/S1474-4422(08)70243-6. Epub 2008 Nov 3.
10
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial.阿苯达唑治疗神经囊尾蚴病的效果:一项随机对照试验。
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1050-5. doi: 10.1136/jnnp.2008.144899. Epub 2008 May 21.